Advertisement

Topics

Puma Biotechnology, Inc. Company Profile

01:50 EST 10th December 2016 | BioPortfolio

Puma Biotechnology, Inc. is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. The Company is initially focused on the development of PB-272 (oral neratinib), a potent irreversible tyrosine kinase inhibitor, for the treatment of patients with HER2 positive metastatic breast cancer.


News Articles [450 Associated News Articles listed on BioPortfolio]

EMA validates Puma Biotechnology's MAA for neratinib

The European Medicines Agency (EMA) has validated Puma Biotechnology's Marketing Authorization Application (MAA) for neratinib.

Puma Biotechnology Prices Public Offering of Common Stock

LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NYSE: PBYI), a biopharmaceutical company, announced the pricing of an underwritten public offering of 3,750,000 shares of its common s...

PUMA INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Puma Biotechnology, Inc. – PBYI

Saturday, October 15th 2016 at 2:07am UTC NEW ORLEANS–(BUSINESS WIRE)– Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti,...

BRIEF-Puma Biotechnology Inc submits MAA for neratinib

* Puma biotechnology submits marketing authorization application (MAA) for PB272 (neratinib) as extended adjuvant treatment of her2-positive early stage breast cancer in europe

Weekly Analysts' Ratings Updates for Puma Biotechnology

They now have an "outperform" rating on the stock. 9/21/2016 - Puma Biotechnology was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating.

Puma Biotech files for EU approval of neratinib in breast cancer

USA-based Puma Biotechnology said today that it has submitted its Marketing Authorization Application…

Weekly Research Analysts' Ratings Changes for Puma Biotechnology

They now have a $46.00 price target on the stock, up previously from $36.00. 7/12/2016 - Puma Biotechnology was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" ratin...

NDA for adjunct breast cancer therapy filed by Puma

A new-drug application has been submitted to the FDA by Puma Biotechnology for its lead product candidate, neratinib, an exte -More- 

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Korres quercetin 7 oak hydrating antiageing and antiwrinkle [Johnson & Johnson Consumer Products Company, Division of Johnson & Johnson Consumer Companies, Inc.]

Korres Quercetin & Oak Day Cream for Normal to Dry Skin SPF 4

Bio-active anti-aging [S.I.P.R.E.S. SRL]

Bio-Active Anti-Aging Cream Multi-Protection Daily Renewal SPF 15 Advanced Double Lifting Effect

Biodynamic skin [S.I.P.R.E.S. SRL]

Biodynamic Skin Solution

PubMed Articles [420 Associated PubMed Articles listed on BioPortfolio]

Bax/Bak activation in the absence of Bid, Bim, Puma, and p53.

How BH3-only proteins activate Bax/Bak, the two gateway proteins of the mitochondria-dependent apoptotic pathway, remains incompletely understood. Although all pro-apoptotic BH3-only proteins are know...

EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis.

Polycomb group (PcG) proteins are highly conserved epigenetic effectors that maintain the silenced state of genes. EZH2 is the catalytic core and one of the most important components of the polycomb r...

Lagochilascaris minor (Nematoda: Ascarididae) from a Wild Cougar ( Puma concolor ) in Mexico.

 We document parasitation of a wild cougar ( Puma concolor ) by the nematode Lagochilascaris minor in Hidalgo State, Mexico. This finding contributes to our understanding of the epidemiology of this...

Students' knowledge of, and attitudes towards biotechnology revisited, 1995-2014: Changes in agriculture biotechnology but not in medical biotechnology.

Modern biotechnology is one of the most important scientific and technological revolutions in the 21st century, with an increasing and measurable impact on society. Development of biotechnology curric...

Quantification of Unmethylated Alu (QUAlu): a tool to assess global hypomethylation in routine clinical samples.

Hypomethylation of DNA is a hallmark of cancer and its analysis as tumor biomarker has been proposed, but its determination in clinical settings is hampered by lack of standardized methodologies. Here...

Clinical Trials [8 Associated Clinical Trials listed on BioPortfolio]

A Pilot Scheme - Specimen Collection of Health Management Center

Biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future. The development of biomedical depends on a high quality academic resea...

A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors

In the laboratory, Kevetrin activates p53, a tumor suppressor protein that has an important role in protecting the body. p53 functions by activating proteins that repair DNA and kill cells...

A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants

In order to evaluate immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine produced by Beijing Minhai Biotechnology Co., Ltd., a randomized, double-blind, parallel-contro...

Dose Escalation Study to Evaluate Oral Rotavirus Vaccine 116E Live Attenuated in Healthy Infants 8 to 20 Weeks Old

This study will be a Phase I, randomized, double blind, safety and immunogenicity trial of the Vero cell based 116E neonatal rotavirus vaccine candidate strain in healthy non-malnourished ...

A Phase III Clinical Trial of An Inactivated Quadrivalent Influenza Vaccine in Healthy Subjects Aged 3 Years and Older

Influenza is an acute respiratory disease caused by influenza viruses. There are three types of the virus including A, B and C. Both type A and type B viruses can cause acute febrile respi...

Companies [875 Associated Companies listed on BioPortfolio]

Puma Biotechnology, Inc.

Puma Biotechnology, Inc. is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer. The Company ...

PUMA

Task Group Public Perceptions of Biotechnology

The Task Group on Public Perceptions of Biotechnology is one of the six Task Groups of the European Federation of Biotechnology. It was established in 1991, to increase public awareness and understand...

Missouri Biotechnology Association

The Missouri Biotechnology Association is focused on maintaining the growth of the biotechnology industry generated by the research and development communities of Missouri. While we have made great st...

Swiss Biotech Association (SBA)

The Swiss Biotech Association (SBA) is the national association representing biotechnology companies, academic institutions, regional biotechnology centres and related organisations throughout Switzer...

More Information about "Puma Biotechnology, Inc." on BioPortfolio

We have published hundreds of Puma Biotechnology, Inc. news stories on BioPortfolio along with dozens of Puma Biotechnology, Inc. Clinical Trials and PubMed Articles about Puma Biotechnology, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Puma Biotechnology, Inc. Companies in our database. You can also find out about relevant Puma Biotechnology, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record